Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-06 | 2023-04-21 | 188973 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-19 | 2023-07-21 | 192800 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-19 | 2023-06-23 | 192818 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-17 | 2017-10-24 | 15995 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-26 | 2017-11-13 | 17331 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-08-19 | 2022-10-14 | 167421 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-09 | 2023-02-02 | 177600 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-02 | 2021-02-23 | 123581 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-17 | 2021-02-23 | 124359 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-07 | 2021-02-23 | 125824 |
| APO-TELMISARTAN | 40MG | TABLET | Resolved | 2018-07-11 | 2018-07-11 | 55290 |
| APO-TELMISARTAN | 40MG | TABLET | Resolved | 2018-07-15 | 2018-09-12 | 55794 |
| APO-TELMISARTAN | 80MG | TABLET | Resolved | 2018-07-15 | 2018-09-12 | 55798 |
| APO-TELMISARTAN | 80MG | TABLET | Resolved | 2017-05-24 | 2017-10-03 | 11047 |
| APO-TELMISARTAN | 40MG | TABLET | Resolved | 2017-06-06 | 2017-10-03 | 12080 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Actual shortage | 2017-05-24 | 2018-12-20 | 11050 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-03-13 | 2017-03-31 | 748 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-04-11 | 2018-09-12 | 6524 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-05-04 | 2018-09-12 | 8922 |
| APO-TENOFOVIR | 300MG | TABLET | Resolved | 2018-07-25 | 2018-09-04 | 56538 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TICAGRELOR | 60MG | TABLET | To be discontinued | 2025-11-12 | 2025-11-20 | 257700 |
| APO-TICAGRELOR | 60MG | TABLET | Discontinued | 2025-11-19 | 2025-11-20 | 257747 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 |